Annual Cash & Cash Equivalents
$8.27 M
-$79.88 M-90.62%
December 31, 2023
Summary
- As of February 7, 2025, CGON annual cash & cash equivalents is $8.27 million, with the most recent change of -$79.88 million (-90.62%) on December 31, 2023.
- During the last 3 years, CGON annual cash & cash equivalents has fallen by -$45.34 million (-84.58%).
- CGON annual cash & cash equivalents is now -90.62% below its all-time high of $88.14 million, reached on December 31, 2022.
Performance
CGON Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$43.41 M
+$18.25 M+72.55%
September 30, 2024
Summary
- As of February 7, 2025, CGON quarterly cash and cash equivalents is $43.41 million, with the most recent change of +$18.25 million (+72.55%) on September 30, 2024.
- Over the past year, CGON quarterly cash and cash equivalents has dropped by -$34.06 million (-43.96%).
- CGON quarterly cash and cash equivalents is now -50.75% below its all-time high of $88.14 million, reached on December 1, 2022.
Performance
CGON Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CGON Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -90.6% | -44.0% |
| 3 y3 years | -84.6% | - |
| 5 y5 years | -84.6% | - |
CGON Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.6% | at low | -50.8% | +425.2% |
| 5 y | 5-year | -90.6% | at low | -50.8% | +425.2% |
| alltime | all time | -90.6% | at low | -50.8% | +425.2% |
CG Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $43.41 M(+72.6%) |
| Jun 2024 | - | $25.16 M(-67.5%) |
| Mar 2024 | - | $77.47 M(+837.2%) |
| Dec 2023 | $8.27 M | $8.27 M(-19.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $10.27 M(-88.3%) |
| Dec 2022 | $88.14 M(+64.4%) | - |
| Dec 2022 | - | $88.14 M |
| Dec 2021 | $53.61 M | - |
FAQ
- What is CG Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CG Oncology?
- What is CG Oncology annual cash & cash equivalents year-on-year change?
- What is CG Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CG Oncology?
- What is CG Oncology quarterly cash and cash equivalents year-on-year change?
What is CG Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of CGON is $8.27 M
What is the all time high annual cash & cash equivalents for CG Oncology?
CG Oncology all-time high annual cash & cash equivalents is $88.14 M
What is CG Oncology annual cash & cash equivalents year-on-year change?
Over the past year, CGON annual cash & cash equivalents has changed by -$79.88 M (-90.62%)
What is CG Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CGON is $43.41 M
What is the all time high quarterly cash and cash equivalents for CG Oncology?
CG Oncology all-time high quarterly cash and cash equivalents is $88.14 M
What is CG Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, CGON quarterly cash and cash equivalents has changed by -$34.06 M (-43.96%)